References
- Gardner P, Schaffner W. Immunization of adults. N Engl J Med 1993; 328(17): 1252–8
- Williams WW, Hickson MA, Kane MA, et al. Immunization policies and vaccine coverage among adults: the risk for missed opportunities. Ann Intern Med 1988; 108 (4): 616–25 [Erratum, Ann Intern Med 1988; 109(4): 348]
- Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993; 269(2): 221–6
- American Academy of Pediatrics, Committee on Infectious Diseases Staff. Report of the Committee on Infectious Diseases. 23d ed. Elk Grove Village, Ill: American Academy of Pediatrics, 1994
- Centers for Disease Control. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991; 40(RR-1): 1–7
- Murphy TV, White KE, Pastor P, et al. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. JAMA 1993; 269(2): 246–8
- Broadhurst LE, Erickson RL, Kelley PW. Decreases in invasive Haemophilus influenza diseases in US Army children, 1984 through 1991. JAMA 1993: 269(2): 227–31
- Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children— United States, 1987–1993. MMWR 1994; 43(8): 144–8
- Centers for Disease Control. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children. MMWR 1993: 42(15): 296–8
- Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991; 40(RR-13): 1–25
- Centers for Disease Control. Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1990; 39(RR-2): 11
- Wood RC, MacDonald KL, White KE, et al. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA 1993: 270(24): 2935–9
- Roome AJ, Walsh SJ, Carter ML, et al. Hepatitis B vaccine responsiveness in Connecticut public safety personnel. JAMA 1993; 270(24): 2931–4
- Centers for Disease Control. Poliomyelitis prevention. MMWR 1982: 31 (3): 22–6, 31–4
- Centers for Disease Control and Prevention. Update: childhood vaccine-preventable diseases— United States, 1994. MMWR 1994; 43(39): 718–20
- Robbins FC. Eradication of polio in the Americas. JAMA 1993: 270(15): 1857–9
- Centers for Disease Control. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine— supplementary statement. MMWR 1987; 36(48): 795–8
- Centers for Disease Control. Varicellazoster immune globulin for the prevention of chickenpox. MMWR 1984; 33(7): 84–90, 95–100
- Dunkle LM, Arvin AM, Whitley RJ, et al. A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med 1991; 325(22): 1539–44
- White CJ, Kuter BJ, Hildebrand CS, et al. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics 1991; 87(5): 604–10
- Lieu TA, Cochi SL, Black SB, et al. Cost- effectiveness of a routine varicella vaccination program for US children. JAMA 1994: 271(5): 375–81
- ACP Task Force on Adult Immunization and Infectious Diseases Society of America. Guide for adult immunization. 2d ed. Philadelphia: American College of Physicians, 1990
- Centers for Disease Control. Prevention and control of influenza. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1992; 41 (RR-9): 1–17
- Rimantadine for prevention and treatment of influenza. Med Lett Drugs Ther 1993; 35(910): 109–10
- Butler JC, Breiman RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1993; 270(15): 1826–31
- Centers for Disease Control. Pneumococcal polysaccharide vaccine. MMWR 1989: 38(5): 64–8, 73–6
- Baltimore RS. New challenges in the development of a conjugate pneumococcal vaccine. (Editorial) JAMA 1992; 268(23): 3366–7
- Centers for Disease Control. Meningococcal vaccines. MMWR 1985; 34(18): 255–9